Use of small RNAs for therapeutic gene silencing: Risk versus benefit

Drug Discovery Today: Technologies

Volumn 7, Issue 1, 2010, Pages

  Börner, Kathleen ^a   Grimm, Dirk ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; MICRORNA; SMALL INTERFERING RNA;

ARTICLE; GENE OVEREXPRESSION; GENE SILENCING; GENE THERAPY; HUMAN; INTOXICATION; LETHALITY; NONHUMAN; PROMOTER REGION; RNA INTERFERENCE; RNA SEQUENCE; SAFETY; VIRAL GENE DELIVERY SYSTEM;

EID: 78649907430     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2010.07.003     Document Type: Review

References (40)

1. A. Fire Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811 (Pubitemid 28099681)
2. D. Castanotto The promises and pitfalls of RNA-interference-based therapeutics Nature 457 2009 426 433
3. D.H. Kim Strategies for silencing human disease using RNA interference Nat. Rev. Genet. 8 2007 173 184
4. A.L. Jackson Expression profiling reveals off-target gene regulation by RNAi Nat. Biotechnol. 21 2003 635 637
5. A.L. Jackson Noise amidst the silence: off-target effects of siRNAs? Trends Genet. 20 2004 521 524
6. R. Kalluri RNA interference: generic block on angiogenesis Nature 452 2008 543 545
7. R.L. Boudreau Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo Mol. Ther. 17 2009 169 175
8. D. Grimm Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways Nature 441 2006 537 541
9. J.L. McBride Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi Proc. Natl. Acad. Sci. U. S. A. 105 2008 5868 5873
10. Grimm, D. et al. Argonaute proteins are key determinants of RNAi efficacy, toxicity and persistence in the adult mouse liver. J. Clin. Inv. (in press)
11. D.H. Kim MicroRNA-directed transcriptional gene silencing in mammalian cells Proc. Natl. Acad. Sci. U. S. A. 105 2008 16230 16235
12. M. Amarzguioui Approaches for chemically synthesized siRNA and vector-mediated RNAi FEBS Lett. 579 2005 5974 5981
13. J.J. Rossi Expression strategies for short hairpin RNA interference triggers Hum. Gene Ther. 19 2008 313 317
14. R.L. Boudreau Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs RNA 14 2008 1834 1844
15. J.C. Giering Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic Mol. Ther. 16 2008 1630 1636
16. H. Xia siRNA-mediated gene silencing in vitro and in vivo Nat. Biotechnol. 20 2002 1006 1010
17. W.G. Cho Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth Proc. Natl. Acad. Sci. U. S. A. 106 2009 7137 7142
18. M.E. Kleinman Sequence- and target-independent angiogenesis suppression by siRNA via TLR3 Nature 452 2008 591 597
19. A.L. Jackson Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application Nat. Rev. Drug Discov. 9 2010 57 67
20. T. Holen Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor Nucleic Acids Res. 30 2002 1757 1766
21. M.T. McManus Small interfering RNA-mediated gene silencing in T lymphocytes J. Immunol. 169 2002 5754 5760
22. D. Castanotto Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC Nucleic Acids Res. 35 2007 5154 5164
23. E. Koller Competition for RISC binding predicts in vitro potency of siRNA Nucleic Acids Res. 34 2006 4467 4476
24. T.A. Vickers Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells Nucleic Acids Res. 35 2007 6598 6610
25. R. Yi Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs RNA 11 2005 220 226
26. R. Yi Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Genes Dev. 17 2003 3011 3016
27. E.M. Ehlert Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system BMC Neurosci. 11 2010 20
28. S. Diederichs Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites Proc. Natl. Acad. Sci. USA 105 2008 9284 9289
29. D. Grimm From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy Curr. Gene Ther. 3 2003 281 304
30. C.C. Chen Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA Gene Ther. 14 2007 11 19
31. C.C. Chen Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9 Mol. Ther. 17 2009 352 359
32. H. Su Essential and overlapping functions for mammalian Argonautes in microRNA silencing Genes Dev. 23 2009 304 317
33. L. Wu Importance of translation and nonnucleolytic ago proteins for on-target RNA interference Curr. Biol. 18 2008 1327 1332
34. K. Keck Rational design leads to more potent RNA interference against hepatitis B virus: factors effecting silencing efficiency Mol. Ther. 17 2009 538 547
35. Y.P. Liu Combinatorial RNAi against HIV-1 using extended short hairpin RNAs Mol. Ther. 17 2009 1712 1723
36. Saayman, S. et al. Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors. Nucleic Acids Res. (in press)
37. H. Doege Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia J. Biol. Chem. 283 2008 22186 22192
38. D. Grimm In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses J. Virol. 82 2008 5887 5911
39. L.H. Vandenberghe Tailoring the AAV vector capsid for gene therapy Gene Ther. 16 2009 311 319
40. S. Beer Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice Mol. Ther. 18 2010 161 170